Home > PS Ratio > INNOVA CAPTAB

INNOVA CAPTAB
PS (Price/Sales) Ratio

The Current P/S Ratio of INNOVA CAPTAB is 4.17.

Share Price ₹906.0Jul 25,2025
Market Cap ₹5,182.0 Cr
Sales-TTM₹1,243.7 CrTTM-Consolidated Results
Price/Sales4.17xCalculated as Market Cap/Sales
Explore Stock Analytics
COMMUNITY POLL
for INNOVA CAPTAB
Please provide your vote to see the results
INNOVA CAPTAB is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PS (Price/Sales) ratio of INNOVA CAPTAB

Price-to-Sales ratio, P/S Multiple, or P/S Ratio is an important valuation multiple that is defined as:

P/S = Market Capitalization / Sales

or, using per-share numbers:

P/S = Stock Price / Sales Per Share

Applying the above formula, P/S ratio of INNOVA CAPTAB is calculated as :

Current Market Cap [ ₹5,182.0 Cr] as on Jul 25,2025

(/) Sales [ ₹1,243.7 Cr] based on TTM-Consolidated Results

(=) P/S Ratio [ 4.17x ]

P/S Ratio indicates 'the multiple of sales' investors are willing to pay to own one share of the company.

Thus, for INNOVA CAPTAB , the investors are currently willing to pay '4.17 times sales' to own 1 share of the company.

PS Multiples are one of the most widely used valuation multiple in the industry.

P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.

You may also explore Price to Earnings ratio or Price to Book ratio of INNOVA CAPTAB !

The chart below summarizes the trend in P/S Ratio of INNOVA CAPTAB over the last five years.

Historical PS (Price/Sales) ratio chart of INNOVA CAPTAB


PS Ratio Performance Analysis for INNOVA CAPTAB

- INNOVA CAPTAB 's latest p/e ratio is 4.17x.

- INNOVA CAPTAB 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.28x.

- INNOVA CAPTAB 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, INNOVA CAPTAB 's p/e ratio peaked in Mar2025 at 4.04x.

- INNOVA CAPTAB 's p/e ratio hit its five-year low in Mar2023 of 0x.


How does INNOVA CAPTAB 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Sales (Cr)PS RatioMarket Cap (Cr)
INNOVA CAPTAB 1,243.74.175,182.0
SUN PHARMACEUTICAL INDUSTRIES LTD52,578.47.75407,551.0
DIVIS LABORATORIES LTD9,360.018.77175,704.0
CIPLA LTD27,811.24.45123,675.0
TORRENT PHARMACEUTICALS LTD11,516.010.59121,925.0
DR REDDYS LABORATORIES LTD33,519.93.18106,626.0
MANKIND PHARMA LTD12,279.38.74107,363.0
ZYDUS LIFESCIENCES LTD23,241.54.2398,278.9
LUPIN LTD22,707.93.9289,109.1
AUROBINDO PHARMA LTD31,723.72.0565,180.5
ABBOTT INDIA LTD6,409.211.2071,761.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs INNOVA CAPTAB 's P/S Ratio

Top 10 Industry PeersPS Ratio
Min industry PS 2.05x
Max industry PS 18.77x
Median industry PS 4.45x
Average industry PS 7.19x



You may also like the below Video Courses